21 January 2024 - Treatment for advanced melanoma is set to become cheaper under the Pharmaceutical Benefits Scheme in the ...
18 January 2024 - Communiques for three HTA Review Reference Committee meetings held in December 2023 are now available. ...
18 January 2024 - In contrast to New Zealand, 2023 saw many new medicines listed on the PBS. ...
5 January 2024 - The Department of Health has published a revised agenda (version 3) for the March 2024 PBAC ...
12 January 2024 - The public summary documents (first time decisions not to recommend and deferrals) from the September 2023 PBAC ...
4 January 2024 - Two draft papers developed to support the deliberations of the HTA Review Reference Committee have been ...
2 January 2024 - From 1 January 2024, Australians with advanced ovarian cancer, CLL, SLL, cystic fibrosis and atypical haemolytic uraemic ...
1 January 2024 - The January 2024 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
22 December 2023 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the September 2023 PBAC ...
23 December 2023 - An AstraZeneca drug’s listing on the PBS from January 1 will see bills fall massively for people ...
22 December 2023 - The PBS Expenditure and Prescriptions Report 1 July 2022 to 30 June 2023 is now available. ...
18 December 2023 - Recommendations made by the PBAC in November 2023 relating to the listing of medicines on the ...
15 December 2023 - The report on the collection of under co-payment data 2022-23 is now available. ...
11 December 2023 - From 1 December 2023, Australians with small cell lung cancer, biliary tract cancer, juvenile idiopathic arthritis and ...
8 December 2023 - Little Jack Roche was five weeks old when diagnosed with cystic fibrosis. The medication that could help ...